Korsana Biosciences, Inc. <KRSA.O>: UBS initiates coverage with buy rating and target price $55
KRSA•Related News
US Stocks Snapshot-Wall St opens higher after August inflation report
SPY•
Coffee Holding FY26 Q3 swings to net income of 1.99 million; net sales fall 9.3% to 21.69 million
JVA•
Wynn Resorts, Limited <WYNN.O>: UBS cuts target price to $138 from $145
WYNN•
Yemen's Houthis reach strategic island at mouth of vital shipping lane
XLE•
Laser Photonics prices $7.9 million public offering at $0.75 per share with warrants
LASE•